# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA631928 | A | Maximum reversion frequency | 32 | ALA1123154 | assay format | Scientific Literature | ||
2. | ALA626451 | A | Relative measure (Rm) of lipophilic/hydrophilic balance from partition chromatography | 46 | ALA1121401 | assay format | Scientific Literature | ||
3. | ALA633895 | P | Ionization constant (pKa) | 181 | ALA1122023 | small-molecule physicochemical format | Scientific Literature | ||
4. | ALA637017 | P | Ionization constant (pKa) | 41 | ALA1121401 | small-molecule physicochemical format | Scientific Literature | ||
5. | ALA633387 | A | log K value (Logarithm of DNA-affinity association constant) | 32 | ALA1123154 | assay format | Scientific Literature | ||
6. | ALA635418 | P | Dissociation constant (pKa) | 27 | ALA1123154 | small-molecule physicochemical format | Scientific Literature | ||
7. | ALA702934 | F | Tumor cell selectivity determined as maximal percent increase in life span (ILSmax) at LD10 dosage level in L1210 cells | Mus musculus | 259 | ALA1122107 | cell-based format | Scientific Literature | |
8. | ALA703726 | F | Drug concentration in mole/kg/day providing 50% extension of life in intraperitoneally implanted leukemia L1210 mice. | Mus musculus | 771 | ALA1122023 | cell-based format | Scientific Literature | |
9. | ALA737402 | T | In vivo toxicity (qd 1-5), determined using the intraperitoneal implantation of L1210 leukemia cells in mice | Mus musculus | 44 | ALA1121401 | organism-based format | Scientific Literature | |
10. | ALA740992 | F | Drug dose in (mg/kg)/day to provide an increase in life span of 40% was determined | Mus musculus | 27 | ALA1121401 | organism-based format | Scientific Literature | |
11. | ALA745949 | F | Percent increase in life span in L1210 assay at the LD10 dose | Mus musculus | 31 | ALA1121401 | organism-based format | Scientific Literature | |
12. | ALA882847 | F | The mutagenic effectiveness, lowest molar concentration required for a constant proportion of revertant colonies (chosen as 50 per 10E8 bacteria) | Salmonella enterica subsp. enterica serovar Typhimurium | 40 | ALA1121401 | organism-based format | Scientific Literature | |
13. | ALA803798 | A | Concentration of drug needed to kill Salmonella Typhimurium strain TA 1537 grown on histidine-enriched medium | Salmonella enterica subsp. enterica serovar Typhimurium | 46 | ALA1121401 | organism-based format | Scientific Literature | |
14. | ALA857830 | F | Mutagenic efficiency, measured as the concentration providing 50% inhibition of Salmonella Typhimurium strain TA 1537 growth in drug induced-mutant colonies | Salmonella enterica subsp. enterica serovar Typhimurium | 43 | ALA1121401 | organism-based format | Scientific Literature | |
15. | ALA813896 | A | Compound concentration in mole/kg/day lethal to 10% of mice | Mus sp. | 771 | ALA1122023 | organism-based format | Scientific Literature |